UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036703
Receipt number R000041820
Scientific Title Bisoprolol Transdermal Patch for Perioperative Care of Non-cardiac Surgery in Patients with Hypertrophic Obstructive Cardiomyopathy
Date of disclosure of the study information 2019/05/10
Last modified on 2019/05/10 11:35:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Bisoprolol Transdermal Patch for Perioperative Care of Non-cardiac Surgery in Patients with Hypertrophic Obstructive Cardiomyopathy

Acronym

Bisoprolol Transdermal Patch for HOCM

Scientific Title

Bisoprolol Transdermal Patch for Perioperative Care of Non-cardiac Surgery in Patients with Hypertrophic Obstructive Cardiomyopathy

Scientific Title:Acronym

Bisoprolol Transdermal Patch for HOCM

Region

Japan


Condition

Condition

Hypertrophic obstructive cardiomyopathy

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the hemodynamic features of patients with HOCM who used the bisoprolol transdermal patch during perioperative care for non-cardiac surgery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Hemodynamic and echocardiographic features before and after patients switched from oral bisoprolol to transdermal patch therapy or started transdermal patch therapy as a new beta blocker medication

Key secondary outcomes

cardiovascular complications (all cause death, cardiac death, heart failure, ventricular tachycardia, and ventricular fibrillation) in the perioperative period


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

consecutive cases of HOCM with the patients using the bisoprolol transdermal patch during perioperative care

Key exclusion criteria

We excluded patients who exhibited only sigmoid septum but without significant hypertrophy.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Yoichi
Middle name
Last name Imori

Organization

Nippon Medical School

Division name

Department of Cardiovascular Medicine

Zip code

113-8603

Address

1-1-5 Sendagi, Bunkyoku,Tokyo 113-8603, Japan

TEL

03-3822-2131

Email

s9012@nms.ac.jp


Public contact

Name of contact person

1st name Yoichi
Middle name
Last name Imori

Organization

Nippon Medial School Hospital

Division name

Department of Cardiovascular Medicine

Zip code

113-8603

Address

1-1-5 Sendagi, Bunkyoku,Tokyo 113-8603, Japan

TEL

03-3822-2131

Homepage URL


Email

s9012@nms.ac.jp


Sponsor or person

Institute

Nippon Medial School Hospital

Institute

Department

Personal name



Funding Source

Organization

Nippon Medial School Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medial School Hospital

Address

1-1-5 Sendagi, Bunkyoku,Tokyo 113-8603, Japan

Tel

0338222131

Email

s9012@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 01 Day

Date of IRB

2016 Year 08 Month 01 Day

Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date

2018 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patients in the current study were retrospectively registered


Management information

Registered date

2019 Year 05 Month 10 Day

Last modified on

2019 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041820


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name